Lonza · 1 day ago
R&D Intern
Lonza is a global leader in life sciences operating across five continents. They are seeking passionate interns to join their team at the Greenwood Campus to assist in various laboratory tasks and support product development efforts.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Assist in the preparation, formulation, and testing of prototypes
Conduct stability, stress, and compatibility studies to support product development
Maintain lab cleanliness, equipment calibration, and inventory organization to ensure efficient operations
Follow safety procedures and quality regulations (e.g., GMP, FDA, ISO)
Support troubleshooting formulation challenges by contributing observations and data from lab tests
Collaborate with cross-functional teams to support investigations and continuous improvement initiatives
Qualification
Required
Experience in lab setting
Ability to work effectively in a team environment
Excellent verbal, written and organizational skills
Understanding of basic lab techniques, measuring equipment, and safety protocols
Enrolled full-time in a Bachelor's Degree Program, in good standing with an accredited educational institution
Rising Junior or Senior
3.0 GPA or higher with no academic or correction action on record
Required to pass drug screen and background check upon offer
Preferred
Degree Programs (including but not limited to): Chemistry, Biology
Benefits
Housing & Stipend
A housing stipend will be offered to assist with living expenses.
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
2026-01-07
2026-01-05
Company data provided by crunchbase